Skip to main content
. Author manuscript; available in PMC: 2023 Jan 1.
Published in final edited form as: Biochem Pharmacol. 2021 Nov 26;195:114859. doi: 10.1016/j.bcp.2021.114859

Figure 7. CCR5 antagonist treatment alleviates vascular injury.

Figure 7.

Representative images from non-ligated and ligated carotid arteries from animals treated or not with maraviroc for 7 days (20mg/kg/day, i.p) (A); Quantification is presented by lumen area (B), Lumen diameter (C), and media area/lumen area. N=5. Data are presented as mean ± standard error of the mean (SEM). *P<0.05 vs non-ligated; #P<0.05 vs ligated + maraviroc.